Regimens of factor VIII administration - Continuous infusion vs. bolus

Haematologica

Volumn 85, Issue 10 SUPPL., 2000, Pages 69-72

  Berntorp, E ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Continuous infusion; Factor IX; Factor VIII; Hemophilia A; Hemophilia B

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CYCLOPHOSPHAMIDE; EMOCLOT; IMMUNOGLOBULIN G; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANTIGEN ANTIBODY COMPLEX; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMMUNOLOGICAL TOLERANCE;

CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DRUG COMBINATIONS; FACTOR IX; FACTOR VII; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; INJECTIONS; ISOANTIBODIES;

EID: 0033710126     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Tolerance induction using the Malmo treatment model 1982-1995
2. Participants of the International Immune Tolerance Study Group (ITSG). The international registry of immune tolerance; 1994 update
3. Adjusted dose continuous infusion of factor VIII in patients with haemophilia
4. Multidose pharmacokinetics of factor IX: Implications for dosing in prophylaxis
5. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII
6. Continuous infusion of factor IX concentrate to induce immune tolerance in two patients with haemophilia B
7. Immune tolerance induction in haemophiliacs with inhibitor to FVIII: High- or low-dose programme